Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus salivarius UCC118 and Reduced Gastrointestinal Infections

Research synthesisVery low evidenceMixed effect size3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial effects of Lactobacillus salivarius UCC118 for reducing gastrointestinal infections, with effect sizes ranging from small to moderate. The evidence is drawn entirely from review articles and a genomic study, with no human trials or doses consistently reported.

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. All studies are reviews or genomic analyses, not primary human intervention trials; no doses, durations, or statistical significance data are reported. The beneficial findings are based on animal models and mechanistic plausibility, not clinical human data.

Generated May 12, 2026
3 of 3 papers
Back to top